Childrens Allegra Allergy Tablet, Orally Disintegrating
NDC Package 41167-4232-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Childrens Allegra Allergy (fexofenadine hydrochloride) tablets is place 1 tablet on tongue; tablet disintegrates, with or without wateradults and children 12 years of age and overtake 2 tablets every 12 hours on an empty stomach; do not take more than 4 tablets in 24 hourschildren 6 to under 12 years of agetake 1 tablet every 12 hours on an empty stomach; do not take more than 2 tablets in 24 hourschildren under 6 years of agedo not useadults 65 years of age and olderask a doctorconsumers with kidney diseaseask a doctor. This formulation utilizes a tablet, orally disintegrating delivery system. Marketed by Chattem, Inc., this product is identified by NDC 41167-4232 and is authorized under FDA application NDA021909.

Identification & Billing

NDC Package Code
41167-4232-1
Package Description
2 BLISTER PACK in 1 CARTON / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Product Code
41167-4232
11-Digit Billing Format
41167423201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
2 EA
RxNorm Crosswalk
  • RxCUI: 997482 - fexofenadine HCl 30 MG Disintegrating Oral Tablet
  • RxCUI: 997482 - fexofenadine hydrochloride 30 MG Disintegrating Oral Tablet
  • RxCUI: 997484 - Childrens Allegra Allergy 30 MG Disintegrating Oral Tablet
  • RxCUI: 997484 - fexofenadine hydrochloride 30 MG Disintegrating Oral Tablet [Allegra]
  • RxCUI: 997484 - Allegra 30 MG Disintegrating Oral Tablet

Clinical Specifications

Proprietary Name
Childrens Allegra Allergy
Non-Proprietary Name
Fexofenadine Hydrochloride
Substance Name
Fexofenadine Hydrochloride
Dosage Form
Tablet, Orally Disintegrating - A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
FEXOFENADINE HYDROCHLORIDE 30 mg/1
Pharmacologic Class
Usage Information
place 1 tablet on tongue; tablet disintegrates, with or without wateradults and children 12 years of age and overtake 2 tablets every 12 hours on an empty stomach; do not take more than 4 tablets in 24 hourschildren 6 to under 12 years of agetake 1 tablet every 12 hours on an empty stomach; do not take more than 2 tablets in 24 hourschildren under 6 years of agedo not useadults 65 years of age and olderask a doctorconsumers with kidney diseaseask a doctor

Regulatory & Marketing

Labeler Name
Chattem, Inc.
Product Type
Human Otc Drug
FDA Application #
NDA021909
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-02-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (41167-4232). Click a package code to view its specific billing and regulatory data.

41167-4232-6
4 BLISTER PACK in 1 CARTON / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 41167-4232-1 identifies a specific commercial package of 2 blister pack in 1 carton / 6 tablet, orally disintegrating in 1 blister pack of Childrens Allegra Allergy, a human over the counter drug labeled by Chattem, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package. This tablet, orally disintegrating is formulated for oral use and contains fexofenadine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chattem, Inc. on January 02, 2014. The current certification is valid through December 31, 2026.

How is this Chattem, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 41167423201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
41167-4232-1
11-Digit CMS (5-4-2)
41167-4232-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.